The use of carvone in consecutive patch testing.


Journal

Contact dermatitis
ISSN: 1600-0536
Titre abrégé: Contact Dermatitis
Pays: England
ID NLM: 7604950

Informations de publication

Date de publication:
Mar 2023
Historique:
revised: 30 10 2022
received: 07 09 2022
accepted: 16 11 2022
pubmed: 19 11 2022
medline: 9 2 2023
entrez: 18 11 2022
Statut: ppublish

Résumé

Carvone (l-carvone) is a mint-tasting flavour additive that most of us is exposed to and can cause allergic contact reactions. To analyse the frequency and the relevance of positive carvone reactions in a dermatitis population. A retrospective analysis of dermatitis patients consecutively tested with carvone from 2017 to 2021. Data were retrieved from the department's patch-test database. Of 3554 patients tested with carvone, 28 (0.79%) had a positive reaction. Carvone-positive patients had higher mean age, were significantly more likely female (p < 0.001) and had often an intraoral/lip involvement (p < 0.001). In the carvone-positive group, 50% (n = 14) had a relevant reaction, and in 4 of 14, the relevance was first revealed after test reading. Of the carvone-positive patients, 18 of 28 did not have a coexisting allergy to a fragrance/flavour allergen and of these 44% had a relevant allergy. The study suggests that a significant fraction of relevant carvone contact allergies may be overlooked if the allergen is not tested. Furthermore, as the exposure is widespread, inclusion of carvone in the Swedish baseline series may be justified even if the contact allergy prevalence is below 1%.

Sections du résumé

BACKGROUND BACKGROUND
Carvone (l-carvone) is a mint-tasting flavour additive that most of us is exposed to and can cause allergic contact reactions.
OBJECTIVES OBJECTIVE
To analyse the frequency and the relevance of positive carvone reactions in a dermatitis population.
METHOD METHODS
A retrospective analysis of dermatitis patients consecutively tested with carvone from 2017 to 2021. Data were retrieved from the department's patch-test database.
RESULTS RESULTS
Of 3554 patients tested with carvone, 28 (0.79%) had a positive reaction. Carvone-positive patients had higher mean age, were significantly more likely female (p < 0.001) and had often an intraoral/lip involvement (p < 0.001). In the carvone-positive group, 50% (n = 14) had a relevant reaction, and in 4 of 14, the relevance was first revealed after test reading. Of the carvone-positive patients, 18 of 28 did not have a coexisting allergy to a fragrance/flavour allergen and of these 44% had a relevant allergy.
CONCLUSIONS CONCLUSIONS
The study suggests that a significant fraction of relevant carvone contact allergies may be overlooked if the allergen is not tested. Furthermore, as the exposure is widespread, inclusion of carvone in the Swedish baseline series may be justified even if the contact allergy prevalence is below 1%.

Identifiants

pubmed: 36399045
doi: 10.1111/cod.14249
pmc: PMC10098734
doi:

Substances chimiques

carvone 75GK9XIA8I
Allergens 0
Perfume 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

206-211

Informations de copyright

© 2022 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd.

Références

Arch Toxicol. 2015 Aug;89(8):1241-55
pubmed: 26138682
J Am Acad Dermatol. 2000 Feb;42(2 Pt 1):177-82
pubmed: 10642670
Med Oral Patol Oral Cir Bucal. 2019 Jan 1;24(1):e1-e7
pubmed: 30573709
Acta Derm Venereol. 2018 Nov 5;98(10):938-942
pubmed: 30085320
Food Chem Toxicol. 2022 May;163 Suppl 1:112975
pubmed: 35364130
Contact Dermatitis. 2008 Oct;59(4):233-7
pubmed: 18844699
Contact Dermatitis. 2008 Jun;58(6):364-5
pubmed: 18503687
Contact Dermatitis. 1993 Sep;29(3):138-43
pubmed: 8222625
Contact Dermatitis. 2021 May;84(5):290-298
pubmed: 33368411
Contact Dermatitis. 1992 May;26(5):332-40
pubmed: 1395597
Contact Dermatitis. 2023 Mar;88(3):206-211
pubmed: 36399045
Acta Derm Venereol. 2012 Mar;92(2):138-43
pubmed: 22170162
Dermatitis. 2022 Jan-Feb 01;33(1):42-50
pubmed: 33867494
Contact Dermatitis. 2017 Oct;77(4):224-230
pubmed: 28524256
Contact Dermatitis. 2015 Oct;73(4):195-221
pubmed: 26179009
Clin Oral Investig. 2014 Jan;18(1):227-37
pubmed: 23455574

Auteurs

Johanna Enberg (J)

Department of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, Malmö, Sweden.
Helsingborg's Hospital, Helsingborg, Sweden.

Nils Hamnerius (N)

Department of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, Malmö, Sweden.

Liv Kroona (L)

Department of Oral Pathology, Malmö University, Malmö, Sweden.

Cecilia Svedman (C)

Department of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, Malmö, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH